Remove Animal Testing Remove Pharma Companies Remove Trials
article thumbnail

SLAS2024 speaker update: How tech is reducing failure rates in clinical trials

Drug Discovery World

He will go on to discuss the company’s move to Phase I clinical trials with a drug targeting Fragile-X Syndrome, a leading cause of autism and intellectual disabilities. The post SLAS2024 speaker update: How tech is reducing failure rates in clinical trials appeared first on Drug Discovery World (DDW).

article thumbnail

4 ways ex vivo models offer Pharma better alternatives to animal testing

Reprocell

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.

article thumbnail

Join DDW for the SLAS2024 Ignite Theater ‘Innovation from lab to patient’

Drug Discovery World

He will also explain the importance of this innovation as a way to mitigate the high failure rates in clinical trials, which historically see 92% of drugs fail despite passing animal tests, leading to significant financial and time losses in the industry (approximately $53 billion for pharma companies annually).

Vaccine 130